MapLight Therapeutics

Clinical-stage biopharma developing oral therapies for central nervous system disorders such as schizophrenia and Alzheimer's disease psychosis.

View on the globe

$373MEquity raised in 2025–20262025 $373M · 2026 — · 1 equity round
$373MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 28 Jul 2025 to 28 Jul 2025, $373M equity disclosed. Earlier rounds exist but are not sourced.28 Jul 2025: Series D, $373M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 20212025Q2Q3Q42026Q2Equity round28 Jul 2025 · Series D · $373M · led by Forbion, Goldman SachsSeries D · $373M
Funding history: 1 round from 28 Jul 2025 to 28 Jul 2025, $373M equity disclosed. Earlier rounds exist but are not sourced.28 Jul 2025: Series D, $373M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourced’212025Q2Q3Q42026Q2Equity round28 Jul 2025 · Series D · $373M · led by Forbion, Goldman Sachs$373M

Funding history 1 round · 2 sources

Earlier rounds not yet sourced. MapLight Therapeutics was founded in 2021 and raised before 28 Jul 2025; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series D
    Amount$373M
    Post-money—
    ✓ Confirmed
    Lead
    Forbion, Goldman Sachs
    Also
    Sanofi, Novo Holdings, 5AM Ventures, Blue Owl, Avego BioScience Capital, T. Rowe Price
    Note
    Co-led by Forbion and Life Sciences at Goldman Sachs Alternatives; T. Rowe Price participated via advised accounts, Blue Owl via Blue Owl Healthcare Opportunities. The August 2026 $150M private placement is a public-company financing and is not recorded. Earlier rounds not sourced.
    Sources
  2. Earlier rounds not yet sourced

Investors 8

  • Forbion1
  • Goldman Sachs1
  • 5AM Ventures
  • Avego BioScience Capital
  • Blue Owl
  • Novo Holdings
  • Sanofi
  • T. Rowe Price

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Redwood City hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. MapLight Therapeutics and its logo are trademarks of their owners, used here for identification only.